These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 31836169)
1. Cerebrospinal fluid and blood lactate concentrations as prognostic biomarkers in dogs with meningoencephalitis of unknown origin. Portero M; Martínez de Merlo E; Pérez C; Benito M; Daza MA; Fragio C Vet J; 2019 Dec; 254():105395. PubMed ID: 31836169 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid lactate in dogs with inflammatory central nervous system disorders. Mariani CL; Nye CJ; Tokarz DA; Green L; Lau J; Zidan N; Early PJ; Guevar J; Muñana KR; Olby NJ; Miles S J Vet Intern Med; 2019 Nov; 33(6):2701-2708. PubMed ID: 31549740 [TBL] [Abstract][Full Text] [Related]
3. Comparison between cerebrospinal fluid and serum lactate concentrations in neurologic dogs with and without structural intracranial disease. Benedicenti L; Gianotti G; Galban EM Can J Vet Res; 2018 Apr; 82(2):97-101. PubMed ID: 29755188 [TBL] [Abstract][Full Text] [Related]
4. Expression of microRNAs miR-21 and miR-181c in cerebrospinal fluid and serum in canine meningoencephalomyelitis of unknown origin. Gaitero L; Russell SJ; Monteith G; LaMarre J Vet J; 2016 Oct; 216():122-4. PubMed ID: 27687938 [TBL] [Abstract][Full Text] [Related]
5. Effect of a constant rate infusion of cytosine arabinoside on mortality in dogs with meningoencephalitis of unknown origin. Lowrie M; Thomson S; Smith P; Garosi L Vet J; 2016 Jul; 213():1-5. PubMed ID: 27240905 [TBL] [Abstract][Full Text] [Related]
6. Meningoencephalitis of unknown origin: investigation of prognostic factors and outcome using a standard treatment protocol. Lowrie M; Smith PM; Garosi L Vet Rec; 2013 May; 172(20):527. PubMed ID: 23462382 [TBL] [Abstract][Full Text] [Related]
7. Corticosteroid monotherapy versus combined cytarabine continuous rate infusion and corticosteroid therapy in dogs with meningoencephalitis of unknown origin: A blinded, randomized, controlled trial. Jones BS; Liebel FX; Fadda A; Martin S; Lawn R; Lazzerini K; Harcourt-Brown T J Vet Intern Med; 2024; 38(3):1618-1625. PubMed ID: 38700360 [TBL] [Abstract][Full Text] [Related]
8. Clinical presentation, diagnostic findings, prognostic factors, treatment and outcome in dogs with meningoencephalomyelitis of unknown origin: A review. Cornelis I; Van Ham L; Gielen I; De Decker S; Bhatti SFM Vet J; 2019 Feb; 244():37-44. PubMed ID: 30825893 [TBL] [Abstract][Full Text] [Related]
9. A newly designed radiation therapy protocol in combination with prednisolone as treatment for meningoencephalitis of unknown origin in dogs: a prospective pilot study introducing magnetic resonance spectroscopy as monitor tool. Beckmann K; Carrera I; Steffen F; Golini L; Kircher PR; Schneider U; Bley CR Acta Vet Scand; 2015 Jan; 57(1):4. PubMed ID: 25637270 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein concentration has limited value in the diagnosis of meningoencephalitis of unknown origin in dogs. Cavalerie R; Santos ACD; Leonardi H; Blond L; Beurlet S; Dumont R; Piazza S J Am Vet Med Assoc; 2024 Apr; 262(4):481-488. PubMed ID: 38266391 [TBL] [Abstract][Full Text] [Related]
11. Assessment of oligoclonal bands in cerebrospinal fluid and serum of dogs with meningoencephalitis of unknown origin. Prümmer JK; Stein VM; Marti E; Lutterotti A; Jelcic I; Schüpbach-Regula G; Buch T; Maiolini A PLoS One; 2023; 18(1):e0280864. PubMed ID: 36696385 [TBL] [Abstract][Full Text] [Related]
12. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs. Zarfoss M; Schatzberg S; Venator K; Cutter-Schatzberg K; Cuddon P; Pintar J; Weinkle T; Scarlett J; Delahunta A J Small Anim Pract; 2006 Oct; 47(10):588-95. PubMed ID: 17004951 [TBL] [Abstract][Full Text] [Related]
13. Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside. Menaut P; Landart J; Behr S; Lanore D; Trumel C Vet Rec; 2008 Feb; 162(8):241-5. PubMed ID: 18296666 [TBL] [Abstract][Full Text] [Related]
14. Treatment of meningoencephalitis of unknown origin in a dog. Behr S; Llabrés-Días FJ; Radaelli ST Vet Rec; 2009 May; 164(20):627-9. PubMed ID: 19448257 [No Abstract] [Full Text] [Related]
15. Risk factors for early death or euthanasia within 100 days of diagnosis in dogs with meningoencephalitis of unknown origin. Lawn RW; Harcourt-Brown TR Vet J; 2022 Sep; 287():105884. PubMed ID: 35987308 [TBL] [Abstract][Full Text] [Related]
16. Role of Portero M; Miró G; Checa R; Martínez de Merlo E; Fragío C; Benito M; Sainz Á; Pérez C Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33802179 [TBL] [Abstract][Full Text] [Related]
17. Survival time and relapse in dogs with meningoencephalomyelitis of unknown origin treated with prednisolone and ciclosporin: a retrospective study. Brady SL; Woodward AP; le Chevoir M Aust Vet J; 2020 Oct; 98(10):491-498. PubMed ID: 32794230 [TBL] [Abstract][Full Text] [Related]
18. On the utility of cerebrospinal fluid biomarkers in canine neurological disorders. Smolek T; Vince-Kazmerova Z; Hanes J; Stevens E; Palus V; Hajek I; Katina S; Novak P; Zilka N Sci Rep; 2024 Oct; 14(1):24129. PubMed ID: 39406773 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers of non-infectious inflammatory CNS diseases in dogs - Where are we now? Part I: Meningoencephalitis of unknown origin. Andersen-Ranberg E; Berendt M; Gredal H Vet J; 2021 Jul; 273():105678. PubMed ID: 34148601 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for 1-week survival in dogs diagnosed with meningoencephalitis of unknown aetiology. Cornelis I; Volk HA; Van Ham L; De Decker S Vet J; 2016 Aug; 214():91-5. PubMed ID: 27387733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]